Sarfez
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 7/1/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (11)
Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone
Started: 6/15/2025
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
Started: 5/1/2025
A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects
Started: 6/15/2025
Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects
Started: 7/1/2025
Immediate Release Torsemide Versus Extended Release Torsemide After Salty Meal
Started: 11/15/2024
Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
Started: 6/15/2024
Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide
Started: 6/30/2021
Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects
Started: 6/19/2017
A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs
Started: 1/15/2025
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure
Started: 5/1/2025